Trends in Survivorship Grant Funding

  1. Office of Cancer Survivorship
  2. Funding and Grants
  3. Trends in Survivorship Grant Funding

Survivorship research includes efforts to understand, prevent, and mitigate acute, long-term, and late-occurring physical, psychological, social, and economic effects of cancer and its treatment, improve care delivery, promote healthy behaviors, develop and sustain research infrastructure, and improve research methodologies for those impacted by cancer. This section provides information and characteristics of NIH survivorship grants funded over the past several years.

Number of Cancer Survivorship Grants

The graph below shows the number of interventional and observational grants, as well as total grants funded from FY 2017 through FY 2023.

From fiscal year 2017 to fiscal year 2023, the total number of grants increased from 68 to 134. The number of interventional grants increased from 37 to 65, and the number of observational grants increased from 31 to 56. Beginning in 2023,13 grants were coded as “Other” because they did not fit into interventional or observational categories.

 

Percentage of Cancer Survivorship Grants by Primary Focus Area

This graph shows the percentage of grants awarded from FY 2017 to FY 2023 within each primary focus area.

From fiscal year 2017 to fiscal year 2023, the largest percentage of grants was awarded to research focusing on late-term and long-term effects, although the overall percentage declined from approximately 51% to approximately 37%. All other primary focus areas accounted for less than approximately 24% of grants. Following late-term and long-term effects, the primary focuses that accounted for the most grants were acute toxicities and care delivery. The primary focuses that accounted for the smallest percentage of grants were methods and measurement, health promotion and lifestyle behaviors, infrastructure, and financial impact.

Adapted from Mollica MA, Tesauro G, Gallicchio L, Guida J, Maher ME, Tonorezos E. Survivorship science at the National Institutes of Health 2017-2021. J Cancer Surviv (2023). https://doi.org/10.1007/s11764-023-01414-0

Last Updated
October 10, 2024